Gritstone Oncology Inc (NASDAQ:GRTS)
| 9.09 Delayed Data As of Dec 06 |  +0.67 / +7.96%Today’s Change | 7.00 Today|||52-Week Range 32.90 | -41.17% Year-to-Date |
Latest GRTS News | Press Releases
No recent news for Gritstone Oncology Inc.
Today’s Trading
| Previous close | 8.42 |
| Today’s open | 8.49 |
| Day’s range | 8.45 - 9.16 |
| Volume | 242,861 |
| Average volume (3 months) | 119,353 |
| Market cap | $327.3M |
Data as of 4:00pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | -423.53% |
| Earnings growth (this year) | +63.53% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 0.8 |
| Price/Sales | 116.09 |
| Price/Book | 1.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EIGREiger BioPharmaceuti... | +0.20 | +1.54% |
| CRBPCorbus Pharmaceutica... | +0.18 | +3.64% |
| OSMTOsmotica Pharmaceuti... | -0.07 | -1.06% |
| MTNBMatinas BioPharma Ho... | +0.37 | +23.87% |
Data as of 6:30pm ET, 12/06/2019
Financials
| Next reporting date | February 12, 2020 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$64.8M |
| Net profit margin | -5,457.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
